top of page

DiaTheris wins first place in >>venture>> startup competition

Aggiornamento: 4 lug 2023


Out of 336 initial submissions across both Business and NPO Tracks, DiaTheris is the winner of Switzerland's leading early-stage startups >>venture>> competition in the vertical “Health and Nutrition” 2023, obtaining 50,000 CHF prize.





DiaTheris is recognized as the most promising startup in the vertical “Health and Nutrition” by a large panel of world-recognized experts from the pharmaceutical and finance industries. DiaTheris is developing the first-ever therapy for type 1 diabetes that enables glycemic control without the associated risks of hypoglycemia or diabetic ketoacidosis. By simplifying and enhancing the treatment of type 1 diabetes, DiaTheris aims to improve the quality of life for patients and their families.


>>venture>> is a joint initiative of ETH Zürich, McKinsey & Company, Knecht Holding, Innosuisse and EPFL and its Advisory Board for this competition is constituted by scientific and economic world top players.


>>venture>> is the leading competition for up-and-coming entrepreneurs in Switzerland.


Founded by Dr. Thomas Knecht in 1997, the competition empowers young innovators to develop their business ideas into startup companies.






150 visualizzazioni0 commenti

Post recenti

Mostra tutti

Comments


bottom of page